Based in Belgium, DENDROGENIX is a startup. Brouky records 1 investor associated with the company.
Dendrogenix is a Belgian biopharmaceutical company developing first-in-class small molecule drugs called Dendrogenins that stimulate cell differentiation and promote neuron and dendritic cell growth to address unmet medical needs in hearing loss and neurological diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.